作者: Edward A. Sausville
DOI:
关键词:
摘要: A surprising outcome of the search for agents that might target signaling systems drive cancer cell growth has been empirical observation many these drugs appear to potentiate effect conventional therapeutic agents. For example, herceptin, in both preclinical [(1)][1] and